The largest database of trusted experimental protocols

Anti ulbp1 3

Manufactured by R&D Systems
Sourced in United States

Anti-ULBP1-3 is a monoclonal antibody that binds to ULBP1, ULBP2, and ULBP3 proteins. ULBPs are ligands for the NKG2D receptor, which is expressed on natural killer cells, CD8+ T cells, and other immune cells. This antibody can be used to detect the expression of ULBP1, ULBP2, and ULBP3 in various research applications.

Automatically generated - may contain errors

5 protocols using anti ulbp1 3

1

Characterizing NKG2D Ligands in Lung Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lung cancer cells were incubated with mouse anti-MICA, anti-MICB, anti-ULBP1-3, and anti-HLA-ABC monoclonal antibodies (mAbs) (R&D systems, Minneapolis, MN, USA) to determine the expression of NKG2D ligands and MHC class I molecules in lung cancer cells. Specific mAbs against NKG2D ligands and MHC class I molecules or the corresponding isotype controls were used at 1 μg in 100 μL cell suspensions. These were followed by the addition of goat anti-mouse PE-conjugated antibody (BD Phamingen Inc., San Diego, CA, USA). The analysis was performed using BD FACSCANTO II (Becton Dickinson and Company, Franklin Lakes, NJ, USA) and FlowJo software (BD Biosciences, Franklin Lakes, NJ, USA). Surface expression levels were measured as mean fluorescence intensity (MFI).
+ Open protocol
+ Expand
2

Quantifying NKG2D Ligand Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the surface expression of the NKG2D ligands on cancer cells, the cells were incubated with mouse anti-MICA, anti-MICB, anti-ULBP1–3 (R&D systems, Minneapolis, MN, USA), which were NKG2D ligand–specific monoclonal antibodies (mAbs), and the corresponding isotype controls at 10 μg/m, followed by incubation with goat anti-mouse-PE conjugated (BD Phamingen Inc., San Diego, CA., USA). The analysis was performed on a FACS Caliber® (Becton Dickinson, Mountain View, CA., USA) using CellQuest software (Becton Dickinson), and the cell surface expression was quantified by the value of the mean fluorescence intensities (MFIs) obtained with the specific mAbs.
+ Open protocol
+ Expand
3

Quantifying NKG2D Ligands on Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the surface expression of the NKG2D ligands on cancer cells, the cells were incubated with mouse anti-MICA, anti-MICB, and anti-ULBP1-3 (R&D Systems), which were NKG2D ligand-specific monoclonal antibodies (mAbs), and the corresponding isotype controls at 10 µg/ml, followed by incubation with the goat anti-mouse-PE conjugated (BD Pharmingen Inc.). The analysis was performed on the FACSCalibur® system using the CellQuest software (both from Becton-Dickinson), and the cell surface expression was quantified from the value of the mean fluorescence intensities (MFI) obtained with the specific mAbs.
+ Open protocol
+ Expand
4

Quantifying NKG2D Ligand Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the surface expressions of NKG2D ligands on cancer cells, the cells were incubated with mouse anti-MICA, anti-MICB, anti-ULBP1-3 (R&D systems, Minneapolis, MN, USA), anti-HLA-ABC (Clone W6/32, Serotec, Oxford, UK) or the corresponding isotype controls at 10 μg/ml and then incubated with goat anti-mouse-PE conjugated (BD Pharmingen Inc., San Diego, CA., USA). The analysis was performed on a FACS Sort® (Becton Dickinson, Mountain View, CA., USA) using Cell Quest software (Becton Dickinson), and cell surface expressions were quantified using mean fluorescence intensities (MFIs). Relative expression ratios were calculated by dividing treated sample MFI by untreated sample MFI without subtracting the MFI of the appropriate isotype control.
+ Open protocol
+ Expand
5

Quantifying NKG2D Ligands on Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the surface NKG2DLs on cancer cells, the cells were incubated with mouse anti-MICA, anti-MICB, anti-ULBP1–3 (R&D systems, Minneapolis, MN, USA), which were NKG2D ligand-specific monoclonal antibodies (mAbs) or the corresponding isotype controls at 1 μg/100 μl followed by incubation with PE goat anti-mouse Ig (BD Phamingen Inc., San Diego, CA, USA). The analysis was performed on the BD FACSCANTO II (Becton Dickinson and Company, Franklin Lakes, NJ, USA) using FlowJo software (BD Biosciences, Franklin Lakes, NJ, USA) and the cell surface expression was quantified by the value of the mean fluorescence intensities (MFI) obtained with the specific mAbs [48 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!